Open Access
Table 2
Characteristics of patients included in the study and wound evolution before and after CACIPLIQ20 treatment. M, male; F, female; F, fibrin; G, granulation tissue; SR, surface reduction; RF, right foot.
| Case # | Age, years, sex | Ulcer location | Ulcer duration | Ulcer size at baseline (cm2) | Aspect at baseline | Appearance after 4 weeks | % SR after 2 weeks | % SR after 4 weeks | % SR after 8 weeks | Healing after 12 weeks | Commments | Follow up (months) | Alive at last follow up |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 87M | Foot, medial aspect | 12 | 0.5 | 100%F | 90%G 10%F | 0% | 0% | 49% | Stopped | Left the study after 8 weeks, AHT | Lost to follow up | |
| 2 | 86F | Foot, medial edge | 6 | 0.45 | 100%F | 20%F 80%G | 44% | 44% | 80% | Healed | Hypertension, myocardial infarction, AHT | 24 | Yes |
| 2 | 86F | Heel | 6 | 1.05 | 30%F 70%G | Healed | 100% | 100% | 100% | Healed | Yes | ||
| 3 | 85F | Left, medial aspect | 10 | 9.1 | 10%F 90%G | 90%G 10%F | 0% | 0% | 23% | Stopped | Bacterial infection between 4 and 8 weeks HTA healed later | 24 | Yes |
| 4 | 83M | Foot, sole | 2 | 5.6 | 30%F 70%G | 100%G | 4% | 36% | 49% | Not healed | Renal dialysis, died months after study completion from unrelated causes, HTA | 16 | Yes |
| 5 | 88M | Big toe, lateral aspect | >18 | 0.99 | 100%F | 70%F 30%G | 19% | 0% | 0% | Not healed | Died from cachexia, HTA, smoker | 2 | No |
| 6 | 93F | Lateral malleolus | 4 | 73.8 | 20%F 80%G | 95%G | 13% | 13% | 27% | Healed other slowly healing ulcers, HTA | Lost to follow up | ||
| 7 | 74M | Foot, lateral edge | >12 | 2.4 | 100%G | 100%G | 37% | 62% | 100% | Healed | 24 | Yes | |
| 8 | 63M | Heel | 7 | 0.7 | 20%F 80%G | 100%G | 14% | 29% | −50% | Not healed | Bacterial infection, bladder carcinoma, HTA | 24 | Yes |
| 9 | 62M | Stump ulcer | 1 | 49 | 20%F | 100%G | 11% | 46% | 100% | Healed | Diabetes | 12 | Yes |
| 9 | 62M | 2 weeks after femoral amputation | 15 | 80%G | 0% | 78% | 100% | Healed | 12 | Yes | |||
| 10 | 89F | >12 | 0.6 | 50%F 50%G | 100%G | 0% | 40% | 100% | Healed | HTA | Lost to follow up | ||
| 11 | 78M | 1 | 41.2 | 90%G | 0% | 24% | 56% | Not healed | 24 | Yes | |||
| 12 | 62M | 2 | 24 | 30% SR stopped the treatment | 20% | 13% | NA | Not healed | Amputation of 4 toes 3 months later then healed with CACIPLIQ20® (outof the study), HTA, diabetes, smoker | 24 | Yes | ||
| Total | 1 healed, remain 13 | 5 healed remain 12 | 7 healed remain 7 | 8 alive |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.